Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals

Journal of Toxicological Sciences

Volumn 28, Issue 2, 2003, Pages 49-57

  Kudo, Naomi ^a   Kawashima, Yoichi ^a  

^a JOSAI UNIVERSITY   (Japan)

Author keywords

Ammonium perfluorooctanoate; Perfluorooctanoic acid; Toxicity; Toxicokinetics

Indexed keywords

CARRIER PROTEIN; PERFLUOROOCTANOIC ACID; SEX HORMONE;

ABSORPTION; ANION TRANSPORT; DRUG DISTRIBUTION; ENTEROHEPATIC CIRCULATION; HALF LIFE TIME; HUMAN; KIDNEY CLEARANCE; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; REVIEW; SEX DIFFERENCE; SPECIES DIFFERENCE; TOXICOKINETICS; URINARY EXCRETION;

ANIMALIA;

EID: 0037787028     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.28.49     Document Type: Review

References (61)

1. M Company (1976): Acute oral toxicity in rats-T-1585.
2. M Company (1977): Ready biodegradation of FC-143(BOD/COD/TOC). 3M Environmental Laboratory, St. Paul, MN.
3. M Company (1980): Ready biodegradation of FC-143(BOD/COD). Lab request No. 5625S, Environmental Laboratory, St. Paul, MN.
4. M Company (1985): Ready biodegradation of FX-1001(BOD/COD). Lab request No. C1006, Environmental Laboratory, St. Paul, MN, February 14.
5. M Company (1987): Activated sludge respiration inhibition test. Lab Request No. E1282. Environmental Laboratory, St. Paul MN.
6. M Company (1999): The science of organic fluorochemistry and perfluorooctane sulfonate: Current summary of human sera, health and toxicology data. February 5.
7. M Company (2000): Voluntary use and exposure information profile for perfluorooctanoic acid and salts. Submission to USEPA, June 8.
8. M Company (2001): Environmental Monitoring-Multi-City Study, 3M Environmental Laboratory, June 25. in:U.S. EPA Administrative Record AR226-1030A.
9. Abdellatif, A.G., Prest, V., Taper, H.S. and Roberfroid, M. (1991): The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol. Appl. Pharamacol., 111, 530-537.
10. Alexander, B.H. (2001). Mortality study of workers employed at the 3M Cottage Grove facility. Final Report. Division of Environmental and Occupational Health, School of Public Health, University of Minnesota, April 26.
11. Bio/dynamics Inc. (1979): An acute inhalation study of T-2305 CoC in the rat. Project No. 78-7184, 3M Company, St. Paul, MN.
12. Burris, J.M., Lundberg, J.L., Olsen, G.W., Simpson, C. and Mandel, J. (2002): Determination of serum half-lives of several fluorochemicals. Interim Report #2, 3M Medical Department.
13. Christopher, B. and Marias, A.J. (1977): 28-day oral toxicity study with FC-143 in albino mice, Final report, Industrial Bio-Test Laboratories, Inc., Study No. 8532-10655, 3M Reference No. T-1742CoC, Lot 269.
14. 14C in rats after a single oral dose. Riker Laboratories, Inc., Subsidiary of 3M, St. Paul, MN.
15. 14C. Riker Laboratories, Inc., Subsidiary of 3M, St. Paul, MN.
16. 14C-perfluorooctanoate. Riker Laboratories, Inc., Subsidiary of 3M, St. Paul, MN.
17. Gilliland, F.D. and Mandel, J.S. (1993): Mortality among employees of a perfluorooctanoic acid production plant. J. Occup. Med., 35, 950-954.
18. Glaza, S.M. (1995): Acute dermal toxicity study of T-6342 in rabbits. Corning Hazelton, Inc., Project ID: HWI50800374, 3M Company, St. Paul, MN.
19. Glaza, S.M. (1997): Acute oral toxicity study of T-6669 in rats. Corning Hazalton Inc. CHW 61001760. Sponsored by 3M Company, St. Paul, Minnesota. January 10.
20. Goldenthal, E.I. (1978a): Ninety-day subacute rat toxicity study. Final report prepared for 3M Company by International Research and Development Corporation, St. Paul, MN. November 6.
21. Goldenthal, E.I. (1978b): Ninety-day subacute rhesus monkey toxicity study. Final report prepared for 3M Company by International Research and Development Corporation, St. Paul, MN. November 10.
22. Gortner, E.G. (1981): Oral teratology study of T-2998 CoC in rats. Safety Evaluation Laboratory and Riker Laboratories, Inc., Experiment No. 0681TB0398, February.
23. Hanhijarvi, H., Ophaug, R.H. and Singer, L. (1982): The sex-related difference in perfluorooctanoate excretion in the rat. Proc. Soc. Exp. Bio. Med., 171, 50-55.
24. Hanhijarvi, H., Ylinen, M., Haaranen, T. and Nevalainen, T. (1988): A proposed species difference in the renal excretion of perfluorooctanoic acid in the beagle dog and rat. In New development of biosciences: Their implications for laboratory animal science (Beynen, A.C. and Solleveld, H.A., eds.), pp. 409-412, Martinus Nijhoff Publishers, Dordrecht, Netherlands.
25. Hatfield, T. (2001): Screening studies on the aqueous photolytic degradation of perfluorooctanoic acid (PFOA). 3M Environmental Laboratory. Lab request number E-00-2192. St. Paul, MN.
26. IARC (1995): Peroxisome proliferation and its role in carcinogenesis. IARC Technical report No. 24. International Agency for Research on Cancer, Lyon, France.
27. Johnson, J.D. (1995): Final Report, Analytical study, single-dose intravenous pharmakokinetics study of T-6067 in rabbits. Study No. AMDT-120694.1. 3M Environmental Technology and Services, St. Paul, MN.
28. 14C] perfluorooctanoate. Fund. Appl. Toxicol., 4, 972-976.
29. Kennedy, G.L. (1985): Dermal toxicity of ammonium perfluorooctanoate. Toxicol. Appl. Pharm., 81, 348-355.
30. Kennedy, G.L., Hall, G.T., Brittelli, M.R., Barnes, J.R. and Chen, H.C. (1986): Inhalation toxicity of ammonium perfluorooctanoate. Food Chem. Toxicol., 24, 1325-1329.
31. Kudo, N., Katakura, M., Sato, Y. and Kawashima, Y. (2002): Sex hormone-regulated renal transport of perfluorooctanoic acid. Chemico-Biol. Interact., 139, 301-316.
32. Metrick, M. and Marias, A.J. (1977): 28-day oral toxicity study with FC-143 in albino rats. Final Report, Industrial Bio-test Laboratories, Study No. 8532-10654, 3M Reference No. T-1742CoC, Lot 269.
33. Nilsson, R., Beije, B., Preat,.V., Erixon, K. and Ramel, C. (1991): On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Chemico-Biol. Interact., 78, 235-250.
34. Ohmori, K., Kudo, N., Katayama, K. and Kawashima, Y. (2003): Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length., Toxicology, 184, 135-140.
35. Olsen, G.W., Gilliland, F.D., Burlew, M.M., Burris, J.M., Mandel, J.S. and Mandel, J.H. (1998a): An epidemiological investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med., 40, 614-622.
36. Olsen, G.W., Gilliland, F.D., Burlew, M.M., Burris, J.M., Mandel, J.S. and Mandel, J.H. (1998b): An epidemiological investigation of plasma cholecystokinin, hepatic function and serum perfluorooctanoic acid levels in production workers. 3M Final Report, Sept. 4.
37. Olsen, G.W., Logan, P.W., Simpson, C.A., Burris, J.M., Burlew, M.M., Lundberg, J.K. and Mandel, J.H. (2001a): Descriptive summary of serum fluorochemical levels among employee participants of the year 2000 Decatur fluorochemical medical surveillance program. Final Report, March 19.
38. Olsen, G.W., Schmickler, M., Tierens, J.M., Logan, P.W., Burris, J.M., Burlew, M.M., Lundberg, J.K. and Mandel, J.H. (2001b): Descriptive summary of serum fluorochemical levels among employee participants of the year 2000 Antwerp fluorochemical medical surveillance program. Final Report, March 19.
39. Olsen, G.W., Madsen, D.C., Burris, J.M. and Mandel, J.H. (2001c): Descriptive summary of serum fluorochemical levels among 236 building employees. Final Report, March 19.
40. Olsen, G.W., Burlew, M.M., Burris, J.M. and Mandel, J.H., (2001d): A cross-sectional analysis of serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to clinical chemistry, thyroid hormone, hematology and urinalysis results from male and female employee participants of the 2000 Antwerp and Decatur fluorochemiocal medical surveillance program. Final Report, 3M Medical Department.
41. Olsen, G.W., Burris, J.M., Lundberg, J.K., Hansen, K.J., Mandel, J.H. and Zobel, L.R. (2002a): Identification of fluorochemicals in human sera. I. American Red Cross adult blood donors. Final Report, 3M Medical Department.
42. Olsen, G.W., Burris, J.M., Lundberg, J.K., Hansen, K.J., Mandel, J.H. and Zobel, L.R. (2002b): Identification of fluorochemicals in human sera. II. Elderly participants of adult changes in thought study. Final Report, 3M Medical Department.
43. Olsen, G.W., Burris, J.M., Lundberg, J.K., Hansen, K.J., Mandel, J.H. and Zobel, L.R. (2002c): Identification of fluorochemicals in human sera. III. Pediatric participants in a group A Streptococci clinical trial investigation. Final Report, 3M Medical Department.
44. Olson, C.T. and Andersen, M.E. (1983): The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol. Appl. Pharmacol., 70, 362-372.
45. O'Malley, K.D. and Ebbens, K.L. (1981): Repeat application 28-day percutaneous absorption study with T-2618CoC in albino rabbits. Riker Laboratories, St. Paul, MN.
46. Ophaug, R.H. and Singer, L. (1980): Metabolic handling of perfluorooctanoic acid in rats. Proc. Soc. Exp. Biol. Med., 163, 19-23.
47. Pace Analytical (1997): Ready biodegradation of FC-126(BOD/COD). 3M Company Lab. Request No. E1282, Minneapolis, MN. May 29.
48. Pace Analytical (2001): The 18-day aerobic biodegradation study of perfluorooctanesulfonyl-based chemistries. 3M Company Request, Contract Analytical Project ID: CA097, Minneapolis, MN. February 23.
49. Palazzolo, M.J. (1993): Thirteen-week dietary toxicity study with T-5180, ammonium perfluorooctanoate (CAS No. 3825-26-1) in male rats. Final report. Laboratory Project Identification HWI 6329-100, Hazelton, Wisconsin Inc.
50. Reiner, E.A. (1978): Fate of fluorochemicals in the environment. Project Number 9970612613. 3M Company, Environmental Laboratory, July 19.
51. Taves, D.R. (1968): Evidence that there are two forms of fluoride in human serum. Nature 217, 1050-1051.
52. Thomford, P.J. (2001a): 26-week capsule toxicity study with ammonium perfluorooctanoate (APFO) in cynomolgus monkeys. Study performed by Covance Laboratories Inc., Madison, WI for APME-Ad-hoc APFO toxicity working. group. Study No. Covance 6329-231. December 18.
53. Thomford, P.J. (2001b): 26-week capsule toxicity study with ammonium perfluorooctanoate (APFO) in cynomolgus monkeys. Study performed by Covance Laboratories Inc., Madison, WI for APME-Ad-hoc APFO toxicity working group. Study No. Covance 6329-230. December 18.
54. Ubel, F.A., Sorenson, S.D. and Roach, C.E. (1980): Health status of plant workers exposed to fluorochemicals-a preliminary report. Am. Ind. Hyg. Assoc. J. 41, 584-589.
55. Vanden Heuvel, J.P., Kuslikis, B.I., Van Ragelghem, M.L. and Peterson, R.E. (1991): Tissue distribution, metabolism and elimination of perfluorooctanoic acid in male and female rats. J. Biochem. Toxicol., 6, 83-92.
56. Vanden Heuvel, J.P., Davis II, J.W., Sommers, R. and Peterson, R.E. (1992): Renal excretion of perfluorooctanoic acid in male rats: Inhibitory effect of testosterone. J. Biochem. Toxicol., 7, 31-36.
57. Yang, Q., Xie, Y. and DePierre, J.W. (2000): Effects of peroxisome proliferators on the thymus and spleen in mice. Clin. Exp. Immunol., 122, 219-226.
58. Yang, Q., Xie, Y., Erickson, A.M., Nelson, B.D. and DePierre, J.W. (2001): Further evidence for the involvement of inhibition of cell proliferation and development in the thymic and splenic atorophy induced by the peroxisome proliferator perfluorooctanoic acid in mice. Biochem. Pharmacol., 62, 1133-1140.
59. Yang, Q., Xie, Y., Alexson, S.E.H., Nelson, B.D. and DePierre, J.W. (2002): Involvement of peroxisome-proliferator-activate receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol., 63, 1893-1900.
60. Ylinen, M., Hanhijarvi, H., Jaakonaho, I. and Peura, P. (1989): Stimulation by estradiol of the urinary excretion of operfluorooctanoic acid in the male rat. Pharmacol. Toxicol., 65, 274-277.
61. Ylinen, M., Kojo, A., Hanhijarvi H. and Peura, P. (1990): Disposition of perfluorooctanoic acid in the rat after single and subchronic administration. Bull. Environ. Contam. Toxicol., 44, 4653.